Hantech Bio-Technology Co., Ltd. (TPEX:1294)
Taiwan · Delayed Price · Currency is TWD 55.70
-1.10 (-1.94%)
Aug 20, 2026, 1:30 PM CST
Hantech Bio-Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 864.73 | 778.54 | 748.42 | 625.14 | 302.52 | 240.29 | |
Revenue Growth | 20.00% | 4.02% | 19.72% | 106.65% | 25.90% | -9.90% |
Cost of Revenue | 554.69 | 489.65 | 442.68 | 344.29 | 175.89 | 139.27 |
Gross Profit | 310.04 | 288.9 | 305.74 | 280.85 | 126.63 | 101.03 |
Selling, General & Admin | 111.92 | 103.16 | 98.17 | 88.34 | 61.11 | 55.51 |
Research & Development | 13.79 | 12.18 | 10.13 | 7.37 | 8.09 | 6.9 |
Operating Expenses | 126.29 | 115.91 | 108.28 | 95.15 | 69.8 | 61.36 |
Operating Income | 183.76 | 172.98 | 197.47 | 185.71 | 56.84 | 39.67 |
Interest Expense | -2.62 | -2.98 | -5.38 | -2.12 | -1.47 | -1.55 |
Interest & Investment Income | 4.51 | 3.28 | 1.39 | 0.65 | 0.27 | 0.05 |
Currency Exchange Gain (Loss) | 0.31 | 0.31 | 0.55 | -0.03 | 2.57 | -0.2 |
Other Non Operating Income (Expenses) | 0.47 | 0.16 | 0.96 | 0.46 | 0.07 | 0.45 |
EBT Excluding Unusual Items | 186.43 | 173.75 | 194.99 | 184.68 | 58.28 | 38.42 |
Gain (Loss) on Sale of Investments | -0.74 | -0.74 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -0.35 | -0.11 | -0.55 | -0 |
Pretax Income | 185.69 | 173.01 | 194.64 | 184.57 | 57.73 | 38.42 |
Income Tax Expense | 36.53 | 33.93 | 39.22 | 37.04 | 11.87 | 7.33 |
Earnings From Continuing Operations | 149.16 | 139.08 | 155.42 | 147.53 | 45.86 | 31.09 |
Minority Interest in Earnings | -0.03 | -0.03 | 0.26 | 0.59 | 1.61 | 1.47 |
Net Income | 149.13 | 139.05 | 155.67 | 148.12 | 47.47 | 32.56 |
Net Income to Common | 149.13 | 139.05 | 155.67 | 148.12 | 47.47 | 32.56 |
Net Income Growth | 3.15% | -10.68% | 5.10% | 212.00% | 45.81% | -41.62% |
Shares Outstanding (Basic) | 36 | 36 | 34 | 33 | 31 | 28 |
Shares Outstanding (Diluted) | 37 | 37 | 35 | 34 | 31 | 29 |
Shares Change | 1.32% | 4.91% | 3.19% | 8.45% | 7.98% | 2.60% |
EPS (Basic) | 4.10 | 3.84 | 4.56 | 4.46 | 1.55 | 1.18 |
EPS (Diluted) | 4.06 | 3.78 | 4.44 | 4.36 | 1.51 | 1.12 |
EPS Growth | 1.90% | -14.82% | 1.86% | 188.00% | 34.69% | -43.03% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 120.89 | 145.19 | 126.13 | -102.03 | -19.7 | -34.87 |
Free Cash Flow Per Share | 3.29 | 3.95 | 3.60 | -3.00 | -0.63 | -1.20 |
Dividend Per Share | 2.500 | 2.500 | 2.667 | 0.582 | 0.506 | - |
Dividend Growth | -6.25% | -6.25% | 357.96% | 15.01% | 74.23% | - |
Gross Margin | 35.85% | 37.11% | 40.85% | 44.93% | 41.86% | 42.04% |
Operating Margin | 21.25% | 22.22% | 26.38% | 29.71% | 18.79% | 16.51% |
Profit Margin | 17.25% | 17.86% | 20.80% | 23.69% | 15.69% | 13.55% |
Free Cash Flow Margin | 13.98% | 18.65% | 16.85% | -16.32% | -6.51% | -14.51% |
EBITDA | 212.68 | 201.21 | 221.24 | 198.27 | 68.54 | 50.96 |
EBITDA Margin | 24.59% | 25.85% | 29.56% | 31.72% | 22.66% | 21.21% |
D&A For EBITDA | 28.92 | 28.23 | 23.77 | 12.56 | 11.71 | 11.29 |
EBIT | 183.76 | 172.98 | 197.47 | 185.71 | 56.84 | 39.67 |
EBIT Margin | 21.25% | 22.22% | 26.38% | 29.71% | 18.79% | 16.51% |
Effective Tax Rate | 19.67% | 19.61% | 20.15% | 20.07% | 20.56% | 19.09% |